EMBL invites researchers, entrepreneurs, investors as well as members of its own community – including alumni and staff – to Dundee, the City of Discovery, for EMBL in the UK 2022. This year, hear how research discoveries can effectively be translated into impact. What lessons can we learn from previous ventures in order to maximise future collaborations?
CLS Impact and Outreach
The results of the 2021 Research Excellence Framework (REF) were announced today. Dundee is the top-ranking University for Biological Sciences research, a position we have maintained since the last REF exercise in 2014. The REF2021 assessment has scored SLS as having a total of 71% of its activities being ‘world leading’ (4*) and 28% of its activities being ‘internationally excellent’ (3*).
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
As part of separate partnerships, Amphista will collaborate with Merck Healthcare and Bristol Myers Squibb to leverage the company’s targeted protein degradation (TPD) technology and generate therapeutics in multiple disease areas.
At the end of last month, members of the Life Sciences community took part in the annual Venture Competition. Venture 2022 is a new business idea competition for all University of Dundee Students, Staff and Recent Graduates. It is the final event of Entrepreneurship Week run by the University's Centre for Entrepreneurship.
Two researchers from the MRC PPU have been awarded places in the Scottish Universities Life Sciences Alliance (SULSA) Forging Futures Scheme. Bill Carton (Sapkota lab) and Emily Dickie (Alessi lab) will represent the University of Dundee in the scheme, which is running for the first time in 2022.
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
The annual Scrips Awards applaud the essential role that the pharmaceutical, biotech and other allied industries play in improving healthcare. The awards span the entire range of industry activities, from new drug launches and clinical trials, to innovative deals, outsourcing and fundraising.
Three PhD students from the MRC PPU have successfully made It through to the final round of the Biotechnology Young Entrepreneurs Scheme (YES). Ailsa Black (Rousseau lab), Bill Carton (Sapkota lab) and Lee Armstrong (Kulathu lab) took part as team “Affinitas Biosciences Ltd” with their idea to supplement a chewing gum with a nanobody that specifically targets and inhibits tooth decaying bacteria.
The University of Glasgow’s Lighthouse Laboratory project has won the Knowledge Exchange/Transfer Initiative of the Year trophy at the seventeenth annual THE Awards.
A fundraising deal to develop the ground-breaking capabilities of a University of Dundee spinout has won a major international award.
The series D round that generated $225 million for the drug discovery firm Exscientia has been named as Global University Venturing’s Deal of the Year Award winner for 2021.
The University of Dundee is one of the best universities in the UK for producing successful spinouts, according to a new report.
The University Spinout Report 2021, carried out by GovGrant, names Dundee as the UK's sixth most successful at commercialising innovation. The University spawned 1.5% of the UK’s spinouts with these companies raising £325.7 million over the past two decades.